Luxoft Expands Public Relations Team with Three New Appointments

1. Home
2. Press Releases
3. Luxoft Expands Public Relations Team with Three New Appointments

KRAKOW, Poland -- Luxoft Holding, Inc (NYSE:LXFT), a global IT service provider, today announced three new appointments to strengthen its External Relations practice (industry analyst, sourcing advisory, and media relations) led by Patrick Corcoran who is now reporting into Luxoft’s Global Marketing unit, led by Vice President, Przemek Berendt.

Robert Maccabe, formerly of Rostrum Communications, joins as Corporate Public Relations (PR) Manager based in London, UK. In his role, Robert is responsible for managing corporate public relations globally and enhancing Luxoft’s media presence across its core verticals that include financial services, automotive, healthcare & life sciences and communications. He is also responsible for driving horizontal coverage on Luxoft’s digital offerings.

Agnieszka Porębska also joins as Luxoft’s Public Relations Manager for Central and Eastern Europe and based in Warsaw, Poland. Agnieszka is responsible for Media Relations and support for Public Affairs in Poland as well as external communications in Russia, Ukraine, Bulgaria and Romania. Agnieszka is a public relations professional with over 15 years of experience, having joined from Linkleaders where she was a PR Director.

Yana Piven has been promoted to Public Relations Manager for Eastern Europe (Ukraine and Russia focused), spending most of her time based in Kiev and Odessa, Ukraine. Yana joined Luxoft in 2015 as an Associate for Global Analyst and Advisor Relations, and will be leveraging her knowledge of the company in her new role.

“We are very excited to expand our entire external relations program and Patrick has set a high bar for our interactions with global stakeholders interested in Luxoft,” said Przemek Berendt, Global Vice President of Marketing at Luxoft. “More importantly, Robert, Yana and Agnieszka are three important additions to our public relations team. Their valuable experience, skills and insight will not only help us build our reputation as a great place to work, they will shape our strategic communications to support our business objectives globally.”

• Clinical Operations: Organizations leveraging Appian have seen numerous benefits, including but not limited to; reduced start-up cycle times by 60 percent, reduced cycle time (end-to-end) by 32 percent, 50 percent reduction in cycle times from RFP development to contract execution and reduced average cycle times to 60 days.
• Regulatory Compliance: The Appian Platform has advanced business process management capabilities that allow you to automate, monitor, and control regulatory efforts during each step of a product’s lifecycle, so applications and processes are compliant throughout the entire process.
• GxP Compliance: Organizations in the cloud can maintain GxP compliance and data integrity on the Appian Cloud by ensuring audit trails, establishing service level agreements (SLAs), and monitoring changes.
• Regulatory Information Management: The Appian approach to Regulatory Information Management (RIM) has helped life sciences organizations successfully manage a regulatory portfolio of thousands of products across over 150 countries, comprising global, regional, and local projects. Using Appian, organizations can increase submission quality and achieve over 99 percent regulatory compliance while decreasing system maintenance costs, organizational complexity, and time to market.

Luxoft will leverage its IT integration expertise, experience of providing IT services to major pharmaceutical companies and 42 global delivery centers to help companies implement these platforms.

“In areas such as drug discovery and regulatory compliance, implementing solutions efficiently and right first time is imperative,” said Sam Mantle, Healthcare & Life Sciences Managing Director at Luxoft. “Appian’s business process management capabilities integrated with professional services from Luxoft will allow Life Sciences companies to better meet their business challenges.”

To learn more about Appian and its work across Life Sciences and Pharma, visit www.appian.com.

Forward-Looking Statements

This news release of Luxoft Holding, Inc (“Luxoft”) contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements include information about possible or assumed future results of our business and financial condition, as well as the results of operations, liquidity, plans and objectives. In some cases, you can identify forward-looking statements by terminology such as “believe,” “may,” “estimate,” “continue,” “anticipate,” “intend,” “should,” “plan,” “expect,” “predict,” “potential,” or the negative of these terms or other similar expressions. These statements are subject to, without limitation, the risk factors discussed under the heading “Risk Factors” in Luxoft’s Annual Report on Form 20-F for the year ended March 31, 2017 and other documents filed with or furnished to the Securities and Exchange Commission by Luxoft. Except as required by law, Luxoft undertakes no obligation to publicly update any forward-looking statements for any reason after the date of this news release whether as a result of new information, future events or otherwise.

All trademarks are recognized and are the property of their respective companies.

Media Inquiries

Patrick R. Corcoran

Global Director, External Relations

212-964-9900 ext. 2453

Press@luxoft.com

Twitter: @Luxoft

Nicole Greggs

Director, Media Relations

+1 703.260.7868

nicole.greggs@appian.com